CRANN, the Science Foundation Ireland funded nanoscience research institute, based at University College Cork and Trinity College Dublin, has announced a new commercial partnership worth over €130,000 with Merck Millipore, a biotech and pharmaceutical company based in Cork. As part of the research programmes, CRANN will assist Merck Millipore to further develop the nanostructures of their products’ artificial membranes, that are widely used for medical and diagnostic devices, and to deliver new products with improved membrane performances. Artificial membranes are used in a wide array of products such as lab filtration devices, antibody screening kits and blood typing products.
The quality of our scientific research speaks for itself with Ireland now ranked 8th globally for materials science research. The research partnership reflects CRANN’s reputation as a leading nanoscience centre, with the infrastructure and expertise to attract partnerships with multinational companies based in Ireland.”
Dr. Diarmuid O’Brien, Executive Director, CRANN, said, “This collaborative research programme with Merck Millipore underlines the strength of our industry engagement programme and clearly demonstrates how academic partnerships with industry provide real and immediate benefits for companies and the economy. By utilising our internationally leading infrastructure, coupled with the expertise of our leading researchers, at Trinity College Dublin and University College Cork, CRANN provides new skills and expertise to industry which enhances our partner companies’ competitiveness.”
Chris Ross, Site Director from Merck Millipore, commenting on his company’s collaboration with CRANN said, “This collaborative research programme with CRANN will strengthen our capabilities in creating new material innovations and enhance our manufacturing processes and capabilities in Cork.”
Picture: Minister Seán Sherlock with Liz Henderson, Membrane Operations Manager, Merck Millipore and Professor Michael Morris, CRANN Principal Investigator.